AHA 2018 | Endoscopic Saphenous-Vein-Graft Harvesting in Patients Undergoing Myocardial Revascularization Surgery

For patients undergoing myocardial revascularization surgery, endoscopic harvesting of saphenous veins in expert hands is similar to traditional methods in terms of events, according to this study presented at the American Heart Association (AHA) Congress and published simultaneously in the New England Journal of Medicine (NEJM).

AHA 2018 | Safenectomía endoscópica en pacientes para cirugía de revascularización miocárdicaThis study, called REGROUP, was able to demonstrate that these patients recover more quickly, getting up to ambulate one or two days after the surgery. There is also less pain and less infections.

 

This work also shows that, at least in the intermediate term, the quality of the vein is not affected by the type of procedure, whether it be open or endoscopic.

 

This study randomized 1150 patients undergoing myocardial revascularization surgery to either conventional (n = 574) or endoscopic saphenous-vein-graft harvesting (n = 576) between 2014 and 2017. It should be noted that all operators were experts, since they had done more than 100 endoscopic harvesting procedures and had a lower than 5% rate of conversion to the conventional method.


Read also: AHA 2018 | New Physical Activity Guidelines Recommend Movement for All Ages.


There were no differences in terms of combined cardiovascular events or the individual endpoints during a mean follow-up of 2.78 years.

 

Original title: Randomized Trial of Endoscopic or Open Vein-Graft Harvesting for Coronary-Artery Bypass.

Reference: Zenati MA et al. N Engl J Med. 2018; Epub ahead of print.

 

safenectomia-endoscopica-articulo-original

safenectomía-endoscopica-presentacion


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Left Main Coronary Artery Disease: Intravascular Imaging-Guided PCI vs. Coronary Artery Bypass Grafting

Multiple randomized clinical trials have demonstrated superior outcomes with coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in patients with left main...

AHA 2025 | OCEAN Study: Anticoagulation vs. Antiplatelet Therapy After Successful Atrial Fibrillation Ablation

After a successful atrial fibrillation (AF) ablation, the need to maintain long-term anticoagulation (AC) remains uncertain, especially considering the very low residual embolic risk...

AHA 2025 | VESALIUS-CV: Evolocumab in High-Cardiovascular-Risk Patients Without Prior MI or Stroke

LDL cholesterol is a well-established factor for cardiovascular disease. Therapy with PCSK9 inhibitors, including evolocumab, has been shown to reduce the risk of cardiovascular...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....